Exaggerated urinary excretion of aquaporin-2 in the pathological state of impaired water excretion dependent upon arginine vasopressin. 1998

T Saito, and S E Ishikawa, and F Ando, and N Okada, and T Nakamura, and I Kusaka, and M Higashiyama, and S Nagasaka, and T Saito
Department of Medicine, Jichi Medical School, Tochigi, Japan.

The present study was undertaken to determine whether urinary excretion of aquaporin-2 (UAQP-2) is of value to diagnose the pathological state of water retention and hyponatremia. UAQP-2 under ad libitum water drinking was 429 fmol/mg creatinine in the patients with water retention, a value significantly greater than that of 153 fmol/mg creatinine in the normal subjects. An acute oral water load test (20 mL/kg BW) was performed in 7 normal subjects (22-25 yr old) and 10 patients with water retention and hyponatremia (55-75 yr old). The percent excretion of the water load was only 30% in the patient group compared with 70% in the control group (P < 0.01). In the control group, minimal urinary osmolality was as low as 131 mosmol/kg H2O, which was responsible for the decrease in plasma arginine vasopressin (AVP) levels after the reduction in plasma osmolality. In the patient group, minimal urinary osmolality was 320 mosmol/kg H2O, and free water clearance remained below 0.6 mL/min after the water load. This impaired water excretion was consistent with the nonsuppressible levels of plasma AVP despite hypoosmolality. The nadir of UAQP-2 was obtained at 60-90 min. The minimal UAQP-2 was reduced to 284 fmol/mg creatinine, a value significantly greater than that of 76 fmol/mg creatinine in the control group. Similar results were obtained in the 6 patients with hypopituitarism, who had impaired water excretion and marked hyponatremia. Water excretion was totally normalized after the replacement of hydrocortisone (excretion of water load, 31% vs. 102%; P < 0.01). Hydrocortisone replacement also significantly reduced the minimal UAQP-2 from 225 to 49 fmol/mg creatinine after the acute oral water load, a value comparable to that in the control subjects. These results indicate that UAQP-2 is a potent marker to diagnose the pathological state of impaired water excretion and hyponatremia, dependent upon AVP, in patients with water retention and hypopituitarism.

UI MeSH Term Description Entries
D007010 Hyponatremia Deficiency of sodium in the blood; salt depletion. (Dorland, 27th ed) Hyponatremias
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011237 Predictive Value of Tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. Negative Predictive Value,Positive Predictive Value,Predictive Value Of Test,Predictive Values Of Tests,Negative Predictive Values,Positive Predictive Values,Predictive Value, Negative,Predictive Value, Positive
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D001127 Arginine Vasopressin The predominant form of mammalian antidiuretic hormone. It is a nonapeptide containing an ARGININE at residue 8 and two disulfide-linked cysteines at residues of 1 and 6. Arg-vasopressin is used to treat DIABETES INSIPIDUS or to improve vasomotor tone and BLOOD PRESSURE. Argipressin,Vasopressin, Arginine,Arg-Vasopressin,Argipressin Tannate,Arg Vasopressin

Related Publications

T Saito, and S E Ishikawa, and F Ando, and N Okada, and T Nakamura, and I Kusaka, and M Higashiyama, and S Nagasaka, and T Saito
January 2003, Clinical endocrinology,
T Saito, and S E Ishikawa, and F Ando, and N Okada, and T Nakamura, and I Kusaka, and M Higashiyama, and S Nagasaka, and T Saito
May 2020, Heart and vessels,
T Saito, and S E Ishikawa, and F Ando, and N Okada, and T Nakamura, and I Kusaka, and M Higashiyama, and S Nagasaka, and T Saito
March 2000, Annals of medicine,
T Saito, and S E Ishikawa, and F Ando, and N Okada, and T Nakamura, and I Kusaka, and M Higashiyama, and S Nagasaka, and T Saito
May 2015, Journal of clinical medicine,
T Saito, and S E Ishikawa, and F Ando, and N Okada, and T Nakamura, and I Kusaka, and M Higashiyama, and S Nagasaka, and T Saito
July 1999, Journal of the American Society of Nephrology : JASN,
T Saito, and S E Ishikawa, and F Ando, and N Okada, and T Nakamura, and I Kusaka, and M Higashiyama, and S Nagasaka, and T Saito
January 2001, Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology,
T Saito, and S E Ishikawa, and F Ando, and N Okada, and T Nakamura, and I Kusaka, and M Higashiyama, and S Nagasaka, and T Saito
December 2010, Acta physiologica (Oxford, England),
T Saito, and S E Ishikawa, and F Ando, and N Okada, and T Nakamura, and I Kusaka, and M Higashiyama, and S Nagasaka, and T Saito
April 2010, Digestive diseases and sciences,
T Saito, and S E Ishikawa, and F Ando, and N Okada, and T Nakamura, and I Kusaka, and M Higashiyama, and S Nagasaka, and T Saito
May 2000, Nephron,
T Saito, and S E Ishikawa, and F Ando, and N Okada, and T Nakamura, and I Kusaka, and M Higashiyama, and S Nagasaka, and T Saito
January 1988, Child nephrology and urology,
Copied contents to your clipboard!